Boston Scientific Corporation (LON:0HOY)
London · Delayed Price · Currency is GBP · Price in USD 105.18
-0.38 (-0.36%)
At close: Aug 1, 2025
Accolade Market Cap
Boston Scientific has a market cap or net worth of 117.92 billion as of August 1, 2025. Its market cap has increased by 34.75% in one year.
Market Cap
117.92B
Enterprise Value
126.77B
Revenue
13.50B
Ranking
n/a
PE Ratio
64.49
Stock Price
$105.18
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 876.49M to 117.92B, an increase of 13,353.19%. That is a compound annual growth rate of 15.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 117.73B | 11.96% |
| Dec 31, 2024 | 105.15B | 58.15% |
| Dec 29, 2023 | 66.49B | 20.88% |
| Dec 30, 2022 | 55.00B | 23.04% |
| Dec 31, 2021 | 44.71B | 18.57% |
| Dec 31, 2020 | 37.70B | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.97B |